Beta-Blockers in Asymptomatic Coronary Artery Disease No Benefit or No Evidence?

被引：11
|
作者：
Steg, Philippe Gabriel [1 ,2 ,3 ,4 ]
De Silva, Ranil [4 ,5 ]
机构：
[1] Hop Bichat Claude Bernard, AP HP, Dept Hosp Univ FIRE, F-75018 Paris, France
[2] Univ Paris Diderot, Paris, France
[3] INSERM, U 1148, Paris, France
[4] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England
[5] Royal Brompton & Harefield NHS Fdn Trust, NIHR, Cardiovasc Biomed Res Unit, London, England
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 64卷 / 03期
关键词：
beta-blockers; coronary artery disease; ACUTE MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES; CARDIOVASCULAR EVENTS; HEART; CARVEDILOL; METOPROLOL; MORTALITY; THERAPY; OUTPATIENTS; MANAGEMENT;
D O I：
10.1016/j.jacc.2014.04.043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：253 / 255
页数：3
相关论文
共 50 条
  • [41] Current Knowledge of Beta-Blockers in Chronic Hemodialysis Patients
    Haddiya, Intissar
    Valoti, Siria
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2023, 16 : 223 - 230
  • [42] Beta-blockers for hypertension
    Wiysonge, Charles S.
    Bradley, Hazel A.
    Volmink, Jimmy
    Mayosi, Bongani M.
    Opie, Lionel H.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (01):
  • [43] Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease
    Petta, Vasiliki
    Perlikos, Fotis
    Loukides, Stelios
    Bakakos, Petros
    Chalkias, Athanasios
    Iacovidou, Nicoletta
    Xanthos, Theodoros
    Tsekoura, Dorothea
    Hillas, Georgios
    HEART FAILURE REVIEWS, 2017, 22 (06) : 753 - 763
  • [44] Beta-blockers in post-infarction with systolic function preserved: useful or redundant?
    Ottani, Filippo
    Staszewsky, Lidia
    Latini, Roberto
    GIORNALE ITALIANO DI CARDIOLOGIA, 2022, 23 (12) : 932 - 937
  • [45] Beta-blockers for hypertension
    Wiysonge, Charles Shey
    Bradley, Hazel A.
    Volmink, Jimmy
    Mayosi, Bongani M.
    Mbewu, Anthony
    Opie, Lionel H.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (11):
  • [46] Beta-blockers and Ambulatory Inotropic Therapy
    Zaghlol, Raja
    Ghazzal, Amre
    Radwan, Sohab
    Zaghlol, Louay
    Hamad, Ahmad
    Chou, Jiling
    Ahmed, Sara
    Hofmeyer, Mark
    Rodrigo, Maria E.
    Kadakkal, Ajay
    Lam, Phillip H.
    Rao, Sriram D.
    Weintraub, William S.
    Molina, Ezequiel J.
    Sheikh, Farooq H.
    Najjar, Samer S.
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (08) : 1309 - 1317
  • [47] Potential effects of beta-blockers in HFpEF
    Tokarczyk, Wojciech
    Urban, Szymon
    Patrzalek, Patryk
    Stolarski, Lukasz
    Iwanek, Gracjan
    Szymanski, Oskar
    Zymlinski, Robert
    HEART FAILURE REVIEWS, 2025, 30 (02) : 357 - 364
  • [48] Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly
    Leitao Filho, Fernando Sergio
    Choi, Lauren
    Sin, Don D.
    CURRENT OPINION IN PULMONARY MEDICINE, 2021, 27 (02) : 125 - 131
  • [49] Meta-Analysis of the Usefulness of Beta-Blockers to Reduce the Risk of Major Adverse Cardiovascular Events in Patients With Stable Coronary Artery Disease Without Prior Myocardial Infarction or Left Ventricular Dysfunction
    Arero, Amanuel Godana
    Vasheghani-Farahani, Ali
    Soltani, Danesh
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 158 : 23 - 29
  • [50] Diastolic dysfunction in pulmonary artery hypertension: Creatine kinase and the potential therapeutic benefit of beta-blockers
    Fowler, Ewan D.
    Drinkhill, Mark J.
    Stones, Rachel
    White, Ed
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2018, 45 (04): : 384 - 389
12345